Screener
Allogene Therapeutics ALLO Business Segments — Net loss
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Allogene Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034585
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Interest expense | (300) | (150) |
| Other income (expenses), net | 212 | 92 |
| Total other income (expenses), net | 3,485 | 5,458 |
| Net loss | (42,607) | (59,733) |
| Other comprehensive income (loss): | ||
| Net unrealized gain (loss) on available-for-sale investments | (452) | 132 |
| Net comprehensive loss | $(43,059) | $(59,601) |
| Net loss per share, basic and diluted | $(0.18) | $(0.28) |
Item 1. Financial Statements - Unaudited
FAQ
- What is Allogene Therapeutics's business segments — net loss?
- Allogene Therapeutics (ALLO) reported business segments — net loss of -$42.61M in Q1 2026.
- How has Allogene Therapeutics's business segments — net loss changed year-over-year?
- Allogene Therapeutics's business segments — net loss increased by 28.7% year-over-year, from -$59.73M to -$42.61M.
- What is the long-term trend for Allogene Therapeutics's business segments — net loss?
- Over 2 years (2023 to 2025), Allogene Therapeutics's business segments — net loss has grown at a -23.6% compound annual growth rate (CAGR), from -$327.27M to -$190.89M.
- What does business segments — net loss mean?
- This metric represents the bottom-line financial result for the segment after accounting for all revenues and operating expenses. For clinical-stage biotech companies, this typically reflects the net cash burn required to fund ongoing research and development. It is the primary measure of the segment's current financial sustainability.
Ask your AI about Allogene Therapeutics's business segments — net loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude